VanEck Merk Gold Trust Financials
This page shows VanEck Merk Gold Trust (OUNZ) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2026 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of VanEck Merk Gold Trust's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
VanEck Merk Gold Trust carries a low D/E ratio of 0.00, meaning only $0.00 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.
VanEck Merk Gold Trust earns a strong 37.6% return on equity (ROE), meaning it generates $38 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 67/100. This is up from 18.8% the prior year.
Key Financial Metrics
Earnings & Revenue
VanEck Merk Gold Trust reported $1.1B in net income in fiscal year 2026. This represents an increase of 249.0% from the prior year.
Cash & Balance Sheet
VanEck Merk Gold Trust had 63M shares outstanding in fiscal year 2026. This represents an increase of 26.0% from the prior year.
Margins & Returns
VanEck Merk Gold Trust's ROE was 37.6% in fiscal year 2026, measuring profit generated per dollar of shareholder equity. This is up 18.8 percentage points from the prior year.
Capital Allocation
OUNZ Income Statement
| Metric | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Income | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | N/A | $388.0M+8160.3% | -$4.8M-102.0% | $238.0M | N/A | $127.9M+100.6% | $63.7M-34.6% | $97.5M |
| EPS (Diluted) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
OUNZ Balance Sheet
| Metric | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.9B+27.2% | $2.3B+29.4% | $1.8B+6.1% | $1.7B+25.1% | $1.3B+5.3% | $1.3B+23.9% | $1.0B+12.6% | $904.2M |
| Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash & Equivalents | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $108K-77.9% | $489K+30.5% | $375K+1784985.7% | $21-100.0% | $13.8M-30.8% | $19.9M+110462000.0% | $18-5.3% | $19 |
| Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $2.9B+27.2% | $2.3B+29.4% | $1.8B+6.1% | $1.7B+26.4% | $1.3B+5.9% | $1.2B+22.0% | $1.0B+12.6% | $904.2M |
| Retained Earnings | $1.5B+44.6% | $1.1B+58.0% | $669.4M-0.7% | $674.2M+54.6% | $436.2M+5.8% | $412.2M+45.0% | $284.3M+28.9% | $220.6M |
OUNZ Financial Ratios
| Metric | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | 17.0%+17.3pp | -0.3%-14.6pp | 14.3% | N/A | 10.3%+4.0pp | 6.3%-4.5pp | 10.8% |
| Return on Assets | N/A | 17.0%+17.3pp | -0.3%-14.6pp | 14.3% | N/A | 10.1%+3.9pp | 6.3%-4.5pp | 10.8% |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt-to-Equity | 0.000.0 | 0.000.0 | 0.000.0 | 0.00-0.0 | 0.010.0 | 0.02+0.0 | 0.000.0 | 0.00 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Frequently Asked Questions
Is VanEck Merk Gold Trust profitable?
Yes, VanEck Merk Gold Trust (OUNZ) reported a net income of $1.1B in fiscal year 2026.
What is VanEck Merk Gold Trust's return on equity (ROE)?
VanEck Merk Gold Trust (OUNZ) has a return on equity of 37.6% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.
What are VanEck Merk Gold Trust's total assets?
VanEck Merk Gold Trust (OUNZ) had $2.9B in total assets as of fiscal year 2026, including both current and long-term assets.
What is VanEck Merk Gold Trust's debt-to-equity ratio?
VanEck Merk Gold Trust (OUNZ) had a debt-to-equity ratio of 0.00 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is VanEck Merk Gold Trust's return on assets (ROA)?
VanEck Merk Gold Trust (OUNZ) had a return on assets of 37.6% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.
How financially healthy is VanEck Merk Gold Trust?
VanEck Merk Gold Trust (OUNZ) scores 28 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.